← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5343 | 26436-5343-1 | Estriol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:388 | 388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-6 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:388 | 388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-100 | 63037-100-10 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:389 | 389 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-117 | 63037-117-05 | Diltiazem HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:389 | 389 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:389 | 389 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-466 | 76154-466-15 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-813 | 76154-813-15 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-830 | 72833-830-10 | Edetate Calcium Disodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:389 | 389 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-327 | 70324-327-01 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-201 | 69761-201-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5325 | 26436-5325-1 | Estriol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:389 | 389 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:389 | 389 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:389 | 389 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:389 | 389 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:390 | 390 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1125 | 73271-1125-1 | TESTOSTERONE 12.5 PEL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:390 | 390 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefepime Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-901 | 69374-901-05 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-470 | 76154-470-15 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-814 | 76154-814-15 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-821 | 72833-821-30 | Edetate Calcium Disodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:390 | 390 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-327 | 70324-327-02 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-7 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-251 | 69761-251-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3010 | 79559-3010-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5502 | 26436-5502-3 | Estriol; Testosterone; Estradiol; Progesterone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1064 | 73013-1064-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:390 | 390 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:390 | 390 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:390 | 390 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-250 | 70092-250-75 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:391 | 391 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0052 | 81483-0052-4 | Tirzepatide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:391 | 391 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefepime Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-925 | 69374-925-10 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-077 | 70324-077-01 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1427 | 5446-1427-01 | Edetate Calcium Disodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:391 | 391 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:391 | 391 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-101 | 69761-101-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3006 | 79559-3006-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-25 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5060 | 71266-5060-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-886 | 69194-886-01 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:391 | 391 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:391 | 391 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-092 | 70092-092-36 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:392 | 392 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-202 | 81375-202-05 | Tropicamide/Phenylephrine Sterile Ophthalmic Solution | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0733 | 5446-0733-01 | Ceftazidime | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-604 | 70004-604-09 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7018 | 71285-7018-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-027 | 70324-027-01 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1428 | 5446-1428-01 | Edetate Calcium Disodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:392 | 392 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:392 | 392 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-151 | 69761-151-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3015 | 79559-3015-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-32 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9180 | 71266-9180-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:392 | 392 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-664 | 70092-664-74 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:392 | 392 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-093 | 70092-093-37 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:393 | 393 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:393 | 393 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ceftazidime | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:393 | 393 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7019 | 71285-7019-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-466 | 76154-466-15 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2401 | 72627-2401-1 | Edetate Disodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:393 | 393 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-900 | 71170-900-01 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-3 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-181 | 69761-181-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3018 | 79559-3018-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:393 | 393 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:393 | 393 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:393 | 393 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:393 | 393 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:393 | 393 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:394 | 394 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:394 | 394 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ceftazidime | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:394 | 394 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6030 | 71285-6030-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:394 | 394 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:394 | 394 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Edetate Disodium | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:394 | 394 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-2 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3020 | 79559-3020-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3020 | 70214-3020-1 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:394 | 394 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:394 | 394 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:394 | 394 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1016 | 73013-1016-1 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:395 | 395 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-144 | 82396-144-05 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-222 | 69623-222-08 | Ceftazidime | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:395 | 395 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8093 | 72196-8093-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8093 | 72196-8093-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-201 | 70731-201-85 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:395 | 395 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-050 | 70713-050-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3037 | 79559-3037-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5010 | 70214-5010-1 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:395 | 395 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:395 | 395 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:395 | 395 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-094 | 70092-094-36 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:396 | 396 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0431 | 71285-0431-1 | Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ceftriaxone Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:396 | 396 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7018 | 72196-7018-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:396 | 396 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:396 | 396 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-2 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:396 | 396 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-148 | 70713-148-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:396 | 396 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:396 | 396 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-02 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:396 | 396 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:396 | 396 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1007 | 73013-1007-1 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:397 | 397 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1003 | 5446-1003-01 | Cefuroxime | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:397 | 397 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8093 | 71285-8093-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7019 | 72196-7019-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:397 | 397 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:397 | 397 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2010 | 70168-2010-1 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-03 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:397 | 397 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:397 | 397 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:397 | 397 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:398 | 398 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6073 | 71285-6073-1 | Vancomycin 1.25gm added to D5W | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4535 | 61141-4535-3 | Cefuroxime Sodium | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:398 | 398 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-544 | 69374-544-10 | Epinephrine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8093 | 71285-8093-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:398 | 398 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-003 | 72055-003-01 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-100 | 63037-100-05 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2020 | 70168-2020-1 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-203 | 73702-203-02 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-250 | 70092-250-75 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-32 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:398 | 398 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:398 | 398 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-910 | 71170-910-25 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:399 | 399 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate 5mg/5ml (1mg/ml syringe) | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:399 | 399 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefuroxime Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:399 | 399 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-306 | 69374-306-10 | Epinephrine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7019 | 71285-7019-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:399 | 399 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:399 | 399 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3022 | 79559-3022-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:399 | 399 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-092 | 70092-092-36 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-6030 | 83863-6030-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-02 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:399 | 399 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-098 | 70092-098-44 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:400 | 400 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8218 | 72682-8218-1 | Testosterone 100mg/Anastrozole 8mg Pellet | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70360-007 | 70360-007-35 | Cefuroxime Sodium | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:400 | 400 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:400 | 400 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7018 | 71285-7018-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-003 | 72055-003-01 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:400 | 400 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-131 | 70713-131-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3012 | 79559-3012-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-15 | Fentanyl | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-093 | 70092-093-37 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:400 | 400 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-01 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:400 | 400 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-509 | 70092-509-35 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:401 | 401 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5008 | 70168-5008-1 | Estradiol 50mg | 2024-2 | valid | 0 | 2026-09-18 |